116 related articles for article (PubMed ID: 2981243)
1. Plasma beta-endorphin levels in primary aldosteronism.
Griffing GT; McIntosh T; Berelowitz B; Hudson M; Salzman R; Manson JA; Melby JC
J Clin Endocrinol Metab; 1985 Feb; 60(2):315-9. PubMed ID: 2981243
[TBL] [Abstract][Full Text] [Related]
2. Plasma immunoreactive gamma melanotropin in patients with idiopathic hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension.
Griffing GT; Berelowitz B; Hudson M; Salzman R; Manson JA; Aurrechia S; Melby JC; Pedersen RC; Brownie AC
J Clin Invest; 1985 Jul; 76(1):163-9. PubMed ID: 4019776
[TBL] [Abstract][Full Text] [Related]
3. Plasma immunoreactive proopiolipomelanocortin-derived peptides in patients with primary hyperaldosteronism, idiopathic hyperaldosteronism with bilateral adrenal hyperplasia, and dexamethasone-suppressible hyperaldosteronism.
Güllner HG; Nicholson WE; Gill JR; Orth DN
J Clin Endocrinol Metab; 1983 Apr; 56(4):853-5. PubMed ID: 6300169
[TBL] [Abstract][Full Text] [Related]
4. Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism.
Miyamori I; Yasuhara S; Matsubara T; Okamoto S; Ikeda M; Koshida H; Morise T; Takeda Y; Takeda R; Vecsei P
Endocrinol Jpn; 1987 Dec; 34(6):809-19. PubMed ID: 2836182
[TBL] [Abstract][Full Text] [Related]
5. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.
Kem DC; Weinberger MH; Higgins JR; Kramer NJ; Gomez-Sanchez C; Holland OB
J Clin Endocrinol Metab; 1978 Apr; 46(4):552-60. PubMed ID: 225341
[TBL] [Abstract][Full Text] [Related]
6. Effects of proopiomelanocortin peptides and angiotensin II on steroidogenesis in isolated aldosteronoma cells.
Pham-Huu-Trung MT; Bogyo A; de Smitter N; Girard F
J Clin Endocrinol Metab; 1985 Sep; 61(3):467-71. PubMed ID: 2991320
[TBL] [Abstract][Full Text] [Related]
7. Pituitary peptides other than ACTH may not be aldosterone secretagogue in primary aldosteronism.
Miyamori I; Koshida H; Matsubara T; Soma R; Takasaki H; Okamoto S; Takeda R
Exp Clin Endocrinol; 1990 Aug; 95(3):323-9. PubMed ID: 2174003
[TBL] [Abstract][Full Text] [Related]
8. Effect of naloxone on the adrenal cortex in primary aldosteronism.
Fallo F; Boscaro M; Sonino N; Mantero F
Am J Hypertens; 1988 Jul; 1(3 Pt 1):280-2. PubMed ID: 2839206
[TBL] [Abstract][Full Text] [Related]
9. Nocturnal, daytime, and postural changes of plasma aldosterone before and during dexamethasone in adenomatous and idiopathic aldosteronism.
Hoefnagels WH; Drayer JI; Smals AG; Benraad TJ; Kloppenborg PW
J Clin Endocrinol Metab; 1980 Dec; 51(6):1330-4. PubMed ID: 7440698
[TBL] [Abstract][Full Text] [Related]
10. Effects of naloxone on adrenal cortex regulation in patients with primary aldosteronism.
Fallo F; Boscaro M; Sonino N; Mantero F
J Endocrinol Invest; 1988 Apr; 11(4):261-5. PubMed ID: 2970500
[TBL] [Abstract][Full Text] [Related]
11. The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels.
Kem DC; Tang K; Hanson CS; Brown RD; Painton R; Weinberger MH; Hollifield JW
J Clin Endocrinol Metab; 1985 Jan; 60(1):67-73. PubMed ID: 3964794
[TBL] [Abstract][Full Text] [Related]
12. beta-Endorphin stimulates plasma renin and aldosterone release in normal human subjects.
Rabinowe SL; Taylor T; Dluhy RG; Williams GH
J Clin Endocrinol Metab; 1985 Mar; 60(3):485-9. PubMed ID: 3156142
[TBL] [Abstract][Full Text] [Related]
13. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism.
Biglieri EG; Schambelan M
J Clin Endocrinol Metab; 1979 Jul; 49(1):87-91. PubMed ID: 447820
[TBL] [Abstract][Full Text] [Related]
14. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
Witzgall H; Lorenz R; von Werder K; Weber PC
Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
[TBL] [Abstract][Full Text] [Related]
15. Beta-endorphin attenuates the serum cortisol response to exogenous adrenocorticotropin.
Beyer HS; Parker L; Li CH; Stuart D; Sharp BM
J Clin Endocrinol Metab; 1986 May; 62(5):808-11. PubMed ID: 3007553
[TBL] [Abstract][Full Text] [Related]
16. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
17. Adrenal steroid responses to ACTH in glucocorticoid-suppressible aldosteronism.
Ganguly A; Weinberger MH; Guthrie GP; Fineberg NS
Hypertension; 1984; 6(4):563-7. PubMed ID: 6086520
[TBL] [Abstract][Full Text] [Related]
18. Effect of human beta-endorphin on plasma aldosterone concentrations in normal human subjects.
Kem DC; Feldman M; Starkweather G; Li CH
J Clin Endocrinol Metab; 1985 Mar; 60(3):440-3. PubMed ID: 3156141
[TBL] [Abstract][Full Text] [Related]
19. Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism.
Schambelan M; Brust NL; Chang BC; Slater KL; Biglieri EG
J Clin Endocrinol Metab; 1976 Jul; 43(1):115-31. PubMed ID: 947931
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of plasma atrial natriuretic peptide responses to upright posture and furosemide administration in patients with normal-, low renin essential hypertension and primary aldosteronism.
Sergev O; Rácz K; Varga I; Kiss R; Fütö L; Gutkowska J; Gláz E
Clin Exp Hypertens A; 1991; 13(3):409-23. PubMed ID: 1832596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
